AU778364B2 - Drinkable pharmaceutical solution - Google Patents

Drinkable pharmaceutical solution Download PDF

Info

Publication number
AU778364B2
AU778364B2 AU38252/00A AU3825200A AU778364B2 AU 778364 B2 AU778364 B2 AU 778364B2 AU 38252/00 A AU38252/00 A AU 38252/00A AU 3825200 A AU3825200 A AU 3825200A AU 778364 B2 AU778364 B2 AU 778364B2
Authority
AU
Australia
Prior art keywords
oral pharmaceutical
pharmaceutical suspension
suspension according
mass percentage
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU38252/00A
Other languages
English (en)
Other versions
AU3825200A (en
Inventor
Emmanuel Guerin
Christophe Lebon
Pascal Suplie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Publication of AU3825200A publication Critical patent/AU3825200A/en
Application granted granted Critical
Publication of AU778364B2 publication Critical patent/AU778364B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU38252/00A 1999-04-06 2000-04-06 Drinkable pharmaceutical solution Ceased AU778364B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9904251A FR2791888B1 (fr) 1999-04-06 1999-04-06 Suspension pharmaceutique buvable
FR9904251 1999-04-06
PCT/FR2000/000870 WO2000059468A1 (fr) 1999-04-06 2000-04-06 Suspension pharmaceutique buvable

Publications (2)

Publication Number Publication Date
AU3825200A AU3825200A (en) 2000-10-23
AU778364B2 true AU778364B2 (en) 2004-12-02

Family

ID=9544041

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38252/00A Ceased AU778364B2 (en) 1999-04-06 2000-04-06 Drinkable pharmaceutical solution

Country Status (9)

Country Link
EP (1) EP1165043A1 (fr)
CN (1) CN1351488A (fr)
AU (1) AU778364B2 (fr)
BR (1) BR0009551A (fr)
FR (1) FR2791888B1 (fr)
HU (1) HUP0200711A3 (fr)
IL (1) IL145768A0 (fr)
WO (1) WO2000059468A1 (fr)
ZA (2) ZA200108116B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1411899T3 (da) * 2001-08-01 2009-06-02 Novartis Ag Smagsmaskerende sammensætning
US7300670B2 (en) * 2002-04-03 2007-11-27 Unilab Pharmatech, Ltd. Oral suspension formulation
KR20170052626A (ko) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0413533A1 (fr) * 1989-08-14 1991-02-20 Eurand America, Incorporated Microencapsulation, avec dissimulation de goût, de NSAID insoluble dans l'eau
WO1993012771A1 (fr) * 1991-12-31 1993-07-08 Abbott Laboratories Enrobages de prolamine pour masquer le gout de medicaments s'administrant par voie orale
EP0717992A2 (fr) * 1994-12-21 1996-06-26 McNEIL-PPC, INC. Formulations de suspension aqueuses pour applications pharmaceutiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
DE3900811A1 (de) * 1989-01-13 1990-07-19 Kali Chemie Pharma Gmbh Neue arzneiform
EP0830135A1 (fr) * 1995-05-09 1998-03-25 The Procter & Gamble Company Compositions comprenant du bismuth et un ou plusieurs antimicrobiens, pour la prevention et le traitement de troubles gastro-intestinaux

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0413533A1 (fr) * 1989-08-14 1991-02-20 Eurand America, Incorporated Microencapsulation, avec dissimulation de goût, de NSAID insoluble dans l'eau
WO1993012771A1 (fr) * 1991-12-31 1993-07-08 Abbott Laboratories Enrobages de prolamine pour masquer le gout de medicaments s'administrant par voie orale
EP0717992A2 (fr) * 1994-12-21 1996-06-26 McNEIL-PPC, INC. Formulations de suspension aqueuses pour applications pharmaceutiques

Also Published As

Publication number Publication date
EP1165043A1 (fr) 2002-01-02
ZA200108206B (en) 2002-12-24
AU3825200A (en) 2000-10-23
FR2791888A1 (fr) 2000-10-13
HUP0200711A2 (hu) 2002-07-29
BR0009551A (pt) 2002-05-28
CN1351488A (zh) 2002-05-29
ZA200108116B (en) 2002-09-25
HUP0200711A3 (en) 2003-04-28
WO2000059468A1 (fr) 2000-10-12
FR2791888B1 (fr) 2004-10-08
IL145768A0 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
US20110212182A1 (en) Masked taste pharmaceutical granules/granulates
US20050136114A1 (en) Taste masked pharmaceutical compositions comprising bitter drug and pH sensitive polymer
JP2019196367A (ja) アプレピタント経口液体製剤
CA3129404A1 (fr) Preservation de particules d'api a revetement fonctionnel produites par des procedes de melange sans solvant dans une suspension aqueuse
EP0862421B1 (fr) Compositions pharmaceutiques a liberation rapide
AU771516B2 (en) Drinkable ibuprofen pharmaceutical suspension
US7378109B2 (en) Pharmaceutical composition for improving palatability of drugs and process for preparation thereof
EP2741750A1 (fr) Composition pharmaceutique comprenant du céfuroxime
US20130203721A1 (en) Taste-masked powder for suspension compositions of methylprednisolone
US9040089B2 (en) Oral compositions of clindamycin
AU778364B2 (en) Drinkable pharmaceutical solution
WO1994025006A1 (fr) Compositions pharmaceutiques masquant le gout et leurs procedes de production
WO2004096175A2 (fr) Compositions au gout masque et leurs procedes de preparation
US6515008B1 (en) Formulation
JP4629730B2 (ja) 薬物ののみ易さを改善するための医薬組成物及びその調製方法
EP2558079B1 (fr) Composition sèche de ciprofloxacine pour suspension buvable
FR2791889A1 (fr) Suspension pharmaceutique buvable d'ibuprofene
WO2000016742A1 (fr) Compositions a macher contenant du dextromethorphane